Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alkan Pharma is a prominent Egyptian pharmaceutical manufacturer and a core subsidiary of the Alkan Group. Established in 1994, the company operates a state-of-the-art production facility in 6th of October City that adheres to international Good Manufacturing Practice (GMP) standards. Alkan Pharma specializes in the development, manufacturing, and marketing of a broad range of generic pharmaceutical products across various therapeutic areas, including cardiology, gastroenterology, and anti-infectives. In addition to its proprietary generic line, the company serves as a strategic partner for multinational pharmaceutical firms, providing manufacturing and distribution services within the Egyptian market. Its portfolio includes diverse dosage forms such as tablets, capsules, and liquid preparations. Through its commitment to quality and accessibility, Alkan Pharma has established itself as a key player in the healthcare landscape of the Middle East and Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alkan Pharma.